Pallor
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
124
|
4
|
0.100 |
None |
|
0 |
|
|
|
Persistence of hemoglobin F
|
phenotype |
|
Finding
|
9
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormal bone structure
|
disease |
|
Anatomical Abnormality
|
7
|
|
0.100 |
None |
|
0 |
|
|
|
Hepatomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Finding
|
523
|
30
|
0.100 |
None |
|
0 |
|
|
|
Splenomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
345
|
19
|
0.100 |
None |
|
0 |
|
|
|
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1
|
phenotype |
|
Finding
|
4
|
20
|
0.400 |
None |
1.000 |
1 |
3
|
2015 |
2015 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Oliguria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
1977 |
1977 |
Mean corpuscular hemoglobin concentration determination
|
phenotype |
|
Laboratory Procedure
|
10
|
19
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Finding of Mean Corpuscular Hemoglobin
|
phenotype |
|
Finding
|
653
|
1206
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Red cell distribution width determination
|
phenotype |
|
Laboratory Procedure
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Memory performance
|
phenotype |
|
Mental Process
|
40
|
71
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
RDW - Red blood cell distribution width result
|
phenotype |
|
Laboratory or Test Result
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Mean Corpuscular Volume (result)
|
phenotype |
|
Laboratory or Test Result
|
269
|
549
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Hematocrit procedure
|
phenotype |
|
Laboratory Procedure
|
138
|
216
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
C-reactive protein measurement
|
phenotype |
|
Laboratory Procedure
|
135
|
624
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Blood Sedimentation
|
phenotype |
|
Laboratory Procedure
|
7
|
8
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
response to SSRI
|
phenotype |
|
Cell Function
|
28
|
53
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Blanching of skin
|
phenotype |
|
Sign or Symptom
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Dyskeratosis Congenita
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
58
|
146
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
NADH cytochrome B5 reductase deficiency
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
7
|
45
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Malignant neoplasm of vulva
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
49
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Familial primary pulmonary hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
30
|
2
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Homozygous alpha thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
1992 |
1992 |